# Salicylic Acid Peels Combined With 4% Hydroquinone in the Treatment of Moderate to Severe Melasma in Hispanic Women

> **NCT00616239** · PHASE4 · COMPLETED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 20 (actual)

## Conditions studied

- Melasma

## Interventions

- **DRUG:** 20-30% Salicylic Acid peels to the right side of the face
- **DRUG:** 20-30% Salicylic Acid peels to the left side of the face

## Key facts

- **NCT ID:** NCT00616239
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2018-03
- **Final completion:** 2018-03
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2020-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00616239

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00616239, "Salicylic Acid Peels Combined With 4% Hydroquinone in the Treatment of Moderate to Severe Melasma in Hispanic Women". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00616239. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*